Associated Papers
The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH et al.
Journal of Clinical Immunology, 2023
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Tang J et al.
Theranostics, 2020
32373219 (PubMed )
Supplement: thnov10p5384s2.xlsx › S5-All_HCC_Mutations
Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P et al.
Nature, 2019
31645765 (PubMed )
Supplement: 41586_2019_1689_MOESM10_ESM.xlsx › Sheet1
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA.
Mizuno K et al.
Scientific Reports, 2019
31641155 (PubMed )
Supplement: 41598_2019_51459_MOESM2_ESM.xlsx › S4
Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E et al.
Diagnostic Pathology, 2016
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K et al.
Oncoimmunology, 2013
Select a paper to view details